Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Getting an Innovative Diabetes Product Through CMS - 2017 DiabetesMine Innovation Summit

342 views

Published on

Dan Trodden, VP of Market Access at Insulet Corp. talks about the company's struggles to get the OmniPod tubeless insulin pump approved by CMS -- at the 2017 DiabetesMine Innovation Summit held Friday, Nov. 17, at Stanford School of Medicine.

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this

Getting an Innovative Diabetes Product Through CMS - 2017 DiabetesMine Innovation Summit

  1. 1. Dan Trodden Vice President, Market Access Insulet Corporation
  2. 2. Strategic Approach to Access Payor Evidence Coding Media Publications & Health Technology Assessments HECON Impact and Rate Professional Society Standards and Guidelines Clinical and impact on Patient Outcomes Ensure evidence meets HTA standards Both evidence based and consensus based Capture the voice of the patient Assess fit with existing codes, need for new coding Impacts both coverage as well as rate
  3. 3. Insulet Experience Pursuing Medicare Omnipod Coverage 4 Omnipod System 510(k) Regulatory Clearance 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 20172015
  4. 4. Challenges, learnings, implications for all • Innovation that drives Reimbursement vs Reimbursement that drives Innovation • Collaboration & Coordination • Sustainability -- Supporting the rate of reimbursement 5

×